Alkermes Plc (NASDAQ:ALKS)
| 25.72 BATS BZX Real-Time Price As of 1:48pm ET |  -0.36 / -1.38%Today’s Change | 21.75 Today|||52-Week Range 32.79 | +10.58% Year-to-Date |
Latest ALKS News | Press Releases
| Alkermes (ALKS) Up 4.4% Since Last Earnings Report: Can It Continue? Dec 02 / Zacks.com - Paid Partner Content | How Alkermes (ALKS) Stock Stands Out in a Strong Industry Nov 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 26.08 |
| Today’s open | 26.05 |
| Day’s range | 25.72 - 26.06 |
| Volume | 20,011 |
| Average volume (3 months) | 1,655,852 |
| Market cap | $4.3B |
Data as of 1:48pm ET, 12/05/2022
Growth & Valuation
| Earnings growth (last year) | +57.13% |
| Earnings growth (this year) | -70.09% |
| Earnings growth (next 5 years) | +23.83% |
| Revenue growth (last year) | +13.00% |
| P/E ratio | NM |
| Price/Sales | 3.19 |
| Price/Book | 3.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRGOPerrigo Company PLC | -0.33 | -1.03% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 1:46pm ET, 12/05/2022
Financials
| Next reporting date | February 15, 2023 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | -$48.2M |
| Net profit margin | -4.10% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
